TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC

Patients with head and neck squamous cell carcinoma (HNSCC) continue to have a rather poor prognosis. Treatment-related comorbidities have negative impacts on their quality of life. TRIM21 is a cytosolic E3 ubiquitin ligase that was initially described as an autoantigen in autoimmune diseases and la...

Descripción completa

Detalles Bibliográficos
Autores principales: von Bernuth, Amelie, Ribbat-Idel, Julika, Klapper, Luise, Jagomast, Tobias, Rades, Dirk, Leichtle, Anke, Pries, Ralph, Bruchhage, Karl-Ludwig, Perner, Sven, Offermann, Anne, Sailer, Verena, Idel, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048917/
https://www.ncbi.nlm.nih.gov/pubmed/36982215
http://dx.doi.org/10.3390/ijms24065140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048917/
https://www.ncbi.nlm.nih.gov/pubmed/36982215
http://dx.doi.org/10.3390/ijms24065140

Ejemplares similares